GB0920324D0 - Antibodies - Google Patents

Antibodies

Info

Publication number
GB0920324D0
GB0920324D0 GB0920324A GB0920324A GB0920324D0 GB 0920324 D0 GB0920324 D0 GB 0920324D0 GB 0920324 A GB0920324 A GB 0920324A GB 0920324 A GB0920324 A GB 0920324A GB 0920324 D0 GB0920324 D0 GB 0920324D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0920324A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB SA filed Critical UCB SA
Priority to GB0920324A priority Critical patent/GB0920324D0/en
Publication of GB0920324D0 publication Critical patent/GB0920324D0/en
Priority to PCT/EP2010/067731 priority patent/WO2011061246A2/en
Ceased legal-status Critical Current

Links

GB0920324A 2009-11-19 2009-11-19 Antibodies Ceased GB0920324D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0920324A GB0920324D0 (en) 2009-11-19 2009-11-19 Antibodies
PCT/EP2010/067731 WO2011061246A2 (en) 2009-11-19 2010-11-18 Multivalent antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0920324A GB0920324D0 (en) 2009-11-19 2009-11-19 Antibodies

Publications (1)

Publication Number Publication Date
GB0920324D0 true GB0920324D0 (en) 2010-01-06

Family

ID=41565587

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0920324A Ceased GB0920324D0 (en) 2009-11-19 2009-11-19 Antibodies

Country Status (2)

Country Link
GB (1) GB0920324D0 (en)
WO (1) WO2011061246A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130115215A1 (en) * 2010-07-14 2013-05-09 Hongxing Zhou Domain insertion immunoglobulin
MX2015010146A (en) * 2013-02-08 2016-05-31 Novartis Ag Specific sites for modifying antibodies to make immunoconjugates.
MA44334A (en) 2015-10-29 2018-09-05 Novartis Ag ANTIBODY CONJUGATES INCLUDING A TOLL-TYPE RECEPTOR AGONIST
EP3824906A1 (en) 2016-12-21 2021-05-26 Amgen Inc. Anti-tnf alpha antibody formulations
WO2020181846A1 (en) * 2019-03-11 2020-09-17 凯惠科技发展(上海)有限公司 Cysteine-containing antibody, drug conjugate and use thereof
GB201919062D0 (en) 2019-12-20 2020-02-05 Ucb Biopharma Sprl Antibody
GB201919061D0 (en) 2019-12-20 2020-02-05 Ucb Biopharma Sprl Multi-specific antibody
GB201919058D0 (en) 2019-12-20 2020-02-05 Ucb Biopharma Sprl Multi-specific antibodies
GB202001447D0 (en) 2020-02-03 2020-03-18 Ucb Biopharma Sprl Antibodies
BR112022019047A2 (en) 2020-03-27 2022-11-01 UCB Biopharma SRL AUTONOMOUS KNOB DOMAIN PEPTIDES
IL303295A (en) 2020-12-07 2023-07-01 UCB Biopharma SRL Multispecific antibodies and antibody combinations
GB202111905D0 (en) 2021-08-19 2021-10-06 UCB Biopharma SRL Antibodies

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4741900A (en) 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
DK336987D0 (en) 1987-07-01 1987-07-01 Novo Industri As immobilization
GB8719042D0 (en) 1987-08-12 1987-09-16 Parker D Conjugate compounds
GB8720833D0 (en) 1987-09-04 1987-10-14 Celltech Ltd Recombinant dna product
US5677425A (en) 1987-09-04 1997-10-14 Celltech Therapeutics Limited Recombinant antibody
DE768377T1 (en) 1988-09-02 1998-01-02 Dyax Corp Production and selection of recombinant proteins with different binding sites
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
GB8907617D0 (en) 1989-04-05 1989-05-17 Celltech Ltd Drug delivery system
US5780225A (en) 1990-01-12 1998-07-14 Stratagene Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
AU7247191A (en) 1990-01-11 1991-08-05 Molecular Affinities Corporation Production of antibodies using gene libraries
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5698426A (en) 1990-09-28 1997-12-16 Ixsys, Incorporated Surface expression libraries of heteromeric receptors
DE69129154T2 (en) 1990-12-03 1998-08-20 Genentech, Inc., South San Francisco, Calif. METHOD FOR ENRICHING PROTEIN VARIANTS WITH CHANGED BINDING PROPERTIES
ATE269401T1 (en) 1991-04-10 2004-07-15 Scripps Research Inst LIBRARIES OF HETERODIMERIC RECEPTORS USING PHAGEMIDS
GB9112536D0 (en) 1991-06-11 1991-07-31 Celltech Ltd Chemical compounds
GB9120467D0 (en) 1991-09-26 1991-11-06 Celltech Ltd Anti-hmfg antibodies and process for their production
DE69233782D1 (en) 1991-12-02 2010-05-20 Medical Res Council Preparation of Autoantibodies on Phage Surfaces Starting from Antibody Segment Libraries
US5733743A (en) 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
AU696293B2 (en) 1993-12-08 1998-09-03 Genzyme Corporation Process for generating specific antibodies
PT1231268E (en) 1994-01-31 2005-11-30 Univ Boston BANKS OF POLYCLONE ANTIBODIES
FR2716640B1 (en) 1994-02-28 1996-05-03 Procedes Machines Speciales Device for centering and blocking a workpiece with a view to running it in using an expansion lapper.
US5516637A (en) 1994-06-10 1996-05-14 Dade International Inc. Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
JP2978435B2 (en) 1996-01-24 1999-11-15 チッソ株式会社 Method for producing acryloxypropyl silane
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
GB9625640D0 (en) 1996-12-10 1997-01-29 Celltech Therapeutics Ltd Biological products
JP4108760B2 (en) * 1997-02-21 2008-06-25 ジェネンテック，インコーポレーテッド Antibody fragment-polymer conjugate and humanized anti-IL-8 monoclonal antibody
GB9720054D0 (en) 1997-09-19 1997-11-19 Celltech Therapeutics Ltd Biological products
US20060228364A1 (en) 1999-12-24 2006-10-12 Genentech, Inc. Serum albumin binding peptides for tumor targeting
US6908963B2 (en) 2001-10-09 2005-06-21 Nektar Therapeutics Al, Corporation Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith
AU2004220325B2 (en) * 2003-06-30 2011-05-12 Domantis Limited Polypeptides
JP2007536898A (en) 2003-07-01 2007-12-20 セルテック アール アンド ディ リミテッド Modified antibody Fab fragment
GB0315450D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
GB0315457D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
GB0412181D0 (en) 2004-06-01 2004-06-30 Celltech R&D Ltd Biological products
NZ553500A (en) * 2004-09-23 2009-11-27 Genentech Inc Genentech Inc Cysteine engineered antibodies and conjugates withCysteine engineered antibodies and conjugates with a free cysteine amino acid in the heavy chain a free cysteine amino acid in the heavy chain
GB0514779D0 (en) 2005-07-19 2005-08-24 Celltech R&D Ltd Biological products
GB0619291D0 (en) * 2006-09-29 2006-11-08 Ucb Sa Altered antibodies
KR20100058509A (en) * 2007-07-31 2010-06-03 메디뮨 엘엘씨 Multispecific epitope binding proteins and uses thereof
HUE033438T2 (en) * 2008-09-26 2017-11-28 Ucb Biopharma Sprl Biological products

Also Published As

Publication number Publication date
WO2011061246A2 (en) 2011-05-26
WO2011061246A3 (en) 2011-07-28

Similar Documents

Publication Publication Date Title
IL214996A0 (en) Anti-bcma antibodies
GB0920127D0 (en) Antibodies
GB0909906D0 (en) Antibodies
SG10201401331TA (en) Anti-siglec-15 antibody
EP2427496A4 (en) Anti-vegf-d antibodies
ZA201209004B (en) Anti-fgfr2 antibodies
GB201000467D0 (en) Antibodies
PL3023438T3 (en) Anti-gitr antibodies
IL221371A0 (en) Anti-lrp6 antibodies
GB0821100D0 (en) Antibodies
GB201020738D0 (en) Antibodies
PL2603528T3 (en) Fab-glycosylated antibodies
IL218621A0 (en) Monoclonal antibodies
ZA201302459B (en) Antibodies
ZA201006099B (en) Anti-tyrp1 antibodies
GB0920324D0 (en) Antibodies
GB201002238D0 (en) Antibodies
GB0905972D0 (en) Antibodies against IL-17BR
ZA201007976B (en) Anti-pirb antibodies
EP2499256A4 (en) Anti-c-mpl antibodies
GB0818356D0 (en) Antibodies
GB2473934B (en) Anti-VEEV antibody
GB0908945D0 (en) Antibodies
GB0911712D0 (en) Antibody
GB0823562D0 (en) Antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)